JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8487 Nocodazole
1 Citation

Target: Microtubules/Tubulins

Summary: Tubulin production inhibitor,anti-neoplastic agent

insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
B2176 GSK1059615

Target: PI3K|mTOR

Summary: PI3K and mTOR inhibitor,potent and reversible

insoluble in EtOH; insoluble in H2O; ≥8.33 mg/mL
A8212 PR-619

Target: Deubiquitinating enzymes (DUBs)

Summary: Deubiquitylating enzymes (DBUs) inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
A8218 Lapatinib
2 Citation

Target: ErbB

Summary: EGFR/HER2 inhibitor,potent,selective and reversible

≥29.05 mg/mL
A8215 PP 1

Target: Src|EGFR|JAK|ZAP-70

Summary: Src family tyrosine kinase inhibitor
A8250 LY 294002
16 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A4604 SP 600125
7 Citation

Target: JNK

Summary: JNK1/2/3 inhibitor

insoluble in H2O; ≥11 mg/mL
A1987 Ki16425
4 Citation

Target: LPA Receptors

Summary: LPA receptor antagonist

≥23.75 mg/mL
A5919 AZD7762

Target: Chk

Summary: Checkpoint kinase inhibitor,ATP competitive

insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
C3342 MAZ51

Target: VEGFR

Summary: VEGFR3 antagonist

insoluble in EtOH; insoluble in H2O; ≥31.4 mg/mL